DexCom (NasdaqGS:DXCM) Shares Dip 1% Despite 7% Sales Growth
DexCom (NasdaqGS:DXCM) recently received a warning letter from the FDA, which pointed out issues in manufacturing processes and quality management. While these regulatory developments did not impact ...
Devdiscourse14h
USDA Scraps Food Safety Committees Amid Oversight Concerns
The U.S. Department of Agriculture has dissolved two key food safety advisory committees, sparking concern over government ...
North American Morning Briefing: Stock Futures Drop After Trump Fails to Rule Out Recession
Stock futures and bond yields fell early on Monday after President Trump did not rule out the possibility that his policies would cause a recession and data showed deflationary pressures building in ...
Barchart on MSN1h
Stocks Set to Open Sharply Lower as U.S. Recession Talk Lingers, Inflation Data Awaited
Real-time index price for Dow Jones Industrials Average (DOWI), along with buy or sell indicators, analysis, charts, historical performance, news and more ...
Dexcom (DXCM) Receives a Buy from Piper Sandler
Piper Sandler analyst Matthew O’Brien maintained a Buy rating on Dexcom (DXCM – Research Report) today and set a price target of $100.00. The ...